Andreani OdysseosDr Andreani Odysseos (female), First Time FET Participant, Director of Biomedical Research at EPOS-Iasis and Head of the Translational Nanomedicine and Nanobiotechnology Lab through a special academic appointment at UCY. Combines clinical, translational research and entrepreneurial expertise, skills greatly sought for a research project such as the GIANT Excellence Hub.  Dr Odysseos is a  graduate of University of Athens Medical School and conducted her post-doctoral studies at Dana –Farber Cancer Institute, Discipline of Tumor Immunology. She has been part of the team which identified Lck family of TKR, as a new superfamily of Tyrosine Kinase Receptors that set the bases for the first targeted therapis in Cancer. She did her short-truck Residency in Internal Medicine at Yale Medical School and  and Clinical Research Fellowship at Fred-Hutchinson Cancer Research Center. She has served as an Honorary Research Scientist at the Cyprus Institute of Neurology and Genetics where she established the first primary cancer tissue cultures from patients with gentic predisposition to colorectal cancer as a platform for chemoprevention.

    Research interests: Since the estblishement of EPOS in 2006 through the First Prize of the Cyprus Enterprenurship Competition she has  been leading a vibrant interdisicplinary team for the sift translation of targeted therapies, molecular imaging and nanomedicine –based drug delivery systems. Her research interests include multifactorial, kinase-mediated malignancies, epitomised by malignant gliomas, drug resistance and the role of biological and mechanical barriers in tumor management,  epitomized by the Blood-Brain-Barrier and the mucus barrier in ovarian cancer. She is also interested in emerging concepts  such as Molecular Communications and Nanonetworks and their applicability in the management of highly complex malignancies such as malignant gliomas. Has trained and supervised more than 15 international students and post-docs through MSCAs.

    Research funding: Over the past 10 years Dr Odysseos has attracted national and EC funding, 9 as coordinator, amassing €2,033,496 coordinator and 7 as participant, amassing € 2.418.582. Projects relevant to this proposal: NANORESISTANCE-FP7-IAPP, Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems (Coordinator, , 2011-2015); PATHCHOOSER-FP7-ITN- Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers (participant, 2013-2017). New Generation of Fluorescent Contrast Agents for Inflammatory Bowel Disease and Colorectal Cancer (Coordinator, RPF, 2007-2009); Molecular Markers of Antineoplastic Efficacy of Chromanol Esters (Coordinator, RPF, 2009-2011); Molecular Response Biomarkers of Multipotent Cyanine-Quinazoline Conjugates With Combined Imaging and Therapeutic Properties  (Coordinator, RPF; 2009-2011); Multipotent Theranostic Metal-Based Scaffold for Molecular Targeting of Colorectal Cancer (Coordinator, RPF, 2012-2014); Nanofiber Electrospinning and Rapid Prototyping for Intestinal Tissue Engineering (participant, RPF, 2009-2011); LSH-2003-1.2.1-6. Workshop on the creation of biopharmaceutical development platforms with involvement of Biotech SMEs and Pharmaceutical Industry (EC, 2004-2006). Management Committees of 4 COST Actions, including “CM1106- Chemical Approaches to targeting drug resistance in cancer stem cells”; TD1004: Theranostics Imaging and Therapy: An Action to Develop Nanosized Systems for Imaging Guided Drug Delivery. For her innovative achievements she has been awarded by the Cyprus RPF with 2 Innovation Patent Grants amassing 49, 875 Euros (2012, 2014).

    Research Policy and Scholarly Achievements: Founding Member and Vice-Chair – European Federation of Biotechnology-Section of Medicines Development; Vice-Chairman, Cluster Management Group, EUREKA Cluster on New Safe Medicines Faster; European Commission, DG Research Expert, FP7 Proposal Evaluator for Nanomedicine, People’s Program, Life and ICT programs. EUREKA Organization, Expert, Proposal Evaluator, EUROSTARS Program, 2011-2013. EUREKA Organization, Independent Expert Panel (Nominated by RPF) EUROSTARS Program, 2013; European Commission, European Research Council, Program Evaluator, HORIZON2020, 2014-2020; Ministry of Science, Poland, STRATEGMED Program Evaluator, 2012-2015; Czech Republic, Scientific Research Evaluator, 2013-2014; European Science Foundation –COST Network, Invited Expert, 2015-2020; EuroNanoMed- Invited Expert, 2017. Dr Odysseos has organized and co-chaired premier scientific events including (i) The International Organizing Committee, International Conference on Biology and Treatment of Metastatic Cancers (2016), Cyprus, (ii) International Organizing and Scientific Committee, 1st and 2nd International Conference on Nanotheranostics (ICoN2013/2015), (iii) Chair, Advanced Summer School, “Managing Drug Resistance with Nanomedicine” (2013), (vi) Program Committee and Session Chair,  “Biomarkers in Drug Development”, 13th European Congress of Biotechnology (2007). Active member of the IEEE Communications Society – Emerging Technologies Initiative for Biological and Multiscale Communications (ComSoc). She is the author of 21 papers, 2 chapters, one monograph, 1 editorial, 3 patents, two of which on TKI –based theranostics and nanomedicine, 6 under publication.

    Maria KokonouDr. Maria Kokonou, (female) First Time FET Participant, holds a PhD in Physics from the University of Thessaloniki. She has worked as in prestigious grants including the (i) MSCA-NANORESISTANCE IAPP (20013-2015), where she developed electrospun membranes loaded with TKIs (under patenting) and silica coated nanoparticles (EPOS-Iasis) (ii) RPF -“Molecular Electronics and Photonics” (2012-2013 and the Cyprus University of Technology and Marie-Curie Chair of Excellence (2006-2009) on ‘Nano-heater systems for Thermal NanoManufacturing” at University of Cyprus and 2 other RPF programs at UCY on ‘Nanofiber Electrospinning and Rapid Prototyping for Intestinal Tissue Engineering’ (2009-2011) and “ Vibration Assisted Compaction of Rapidly Solidified Alloy Particles” (2011-2012). She was awarded with a 4-year student fellowship at the Institute of Microoelectronics, Demokritos Science and Research Foundation in Greece and the ‘Thomaidion “Award for Excellence in Science.   She is the author of 21 peer-reviewed papers and 24 abstracts in conference proceedings.

    Kyriacos SpanoudesDr. Kyriacos –Alexandros Spanoudes, (male),  First Time FET Participant: Kyriakos Spanoudes is a registered  Veterinary Surgeon (2013 graduate of Aristotle University of Thessaloniki, Greece) with 5-year experience in experimental surgery, microsurgery, and laboratory animal science, obtained during his PhD (Biomedical Engineering and Regenerative Medicine) at CÚRAM Centre for Research in Medical Devices at the National University of Ireland Galway (NUIG); currently writing up. In addition to his PhD research (which was focused on the fabrication and implantation of collagen-based and electrospun-based modular living tissue analogues), he was the project manager and surgeon in preclinical studies requiring implantation of biomaterial-based advanced therapeutic medicinal products in rodent and rabbit models (e.g. implants for the nervous system, wound healing, osteoporosis, hernia repair and tendon repair). His postgraduate studies have been funded by the Irish Research Council, the NUIG College of Engineering and the EU FP7/2007-2013, Marie Curie, Industry-Academia Partnerships and Pathways (IAPP) award (Tendon Regeneration Project). He has co-authored 11 published peer-reviewed articles, 1 book chapter and >40 conference abstracts in key conferences. Six (6) more research manuscripts and 2 review articles are expected to be published within 12 months. In addition, he was also contributed in teaching biomedical engineering BSc and MSc students, while he participated in numerous outreaching activities of the research group. He in is an active member of the European society of Laboratory Animal Veterinarians (ESLAV), and the European Society for Biomaterials (ESB).

    loizos economidesMr. Loizos Economides, BSc, MSc, MBA (male), First Time FET Participant: Loizos Economides is a holder of a Bachelor of Sciences in Electrical Engineering deg. (Hon) from Boston University, a Master of Sciences in Electrical Engineering deg. (Hon) with specialization in Telecommunications from the University of Pennsylvania and a Master in Business Administration deg. (Hon) with specialization in Marketing and Corporate Strategy from the University of Texas at Austin.  He has extensive experience in the preparation of business plans for international telecommunication projects, international product development and management, negotiations, contract drafting and high level selling of telecommunication services. He will be coordinating the Technology Transfer program and Commercialization strategy.



    Tadashi NakanoTadashi Nakano (male), First Time FET Participant, is an Associate Professor of the Institute of Academic Initiatives, Osaka University, Japan. He received his Ph.D. degree in Information Systems Engineering from Osaka University in 2002. He later worked in the Department of Computer Science, Donald Bren School of Information and Computer Sciences, University of California, Irvine, where he was a Postdoctoral Research Scholar from 2002 to 2007 and an Assistant Adjunct Professor from 2007 to 2009. From 2009 to 2013, he was an Associate Professor at the Graduate School of Engineering, Osaka University. Since 2013, he has been an Associate Adjunct Professor of the Institute of Academic Initiatives, Osaka University, and a Visiting Associate Professor of the Graduate School of Biological Sciences, Osaka University.

    He is currently serving as the Chair of the Emerging Technologies Initiative for Molecular, Biological and Multi-Scale Communications. He is also serving as an Associate Editor of IEEE Transactions on Molecular, Biological and Multi-scale Communications (T-MBMC), an Associate Editor of IEEE Transactions on NanoBioscience (TNB), and an Editor of Elsevier Nano Communication Networks. He has been engaged in research at the intersection of computer science and biology, including design, implementation, and evaluation of molecular communication systems, synthetic biological systems, and biologically inspired systems. Leader of IEEE Communications Society – Emerging Technologies Initiative for Biological and Multiscale Communications (ComSoc).


    Sasitharan BalasubramaniamDr. Sasitharan Balasubramaniam (male), is currently an Acting Director of Research at the Telecommunications Software and Systems Group, Waterford Institute of Technology and also an Academy of Finland Research Fellow at the Department of Electrical and Communication Engineering of the Tampere University of Technology. Dr. Balasubramaniam completed his Bachelors of Electrical and Electronic Engineering and Ph.D. in Computer Science from the University of Queensland, Australia, in 1998 and 2005, respectively. He also completed his Masters of Engineering Science (Computer and Communication Engineering) from the Queensland University of Technology, Australia, in 1999. After the completion of his PhD, he joined the TSSG as a postdoctoral research fellow, and was later promoted to Research Unit Manager.

    The main research interests of Dr. Balasubramaniam lies in Biologically inspired Nanoscale Communications, which also includes molecular communications. In this area he has developed communication models for calcium signalling, bacterial nanonetworks, as well as microfluidic communications. His research interests recently moved towards nanoscale communications within the brain, and this includes modelling the communication within the cortical micro columns as well as implanting nanoscale wireless optogenetic devices that can stimulate single neurons. The aim of this research is to target new forms of Brain-Machine Interfaces that can link machines to stimulations of single neurons. Dr. Balasubramaniam has published 44 peer reviewed journal publications, 66 conference proceedings, 2 book chapters, and has edited a number of special issues in the area of molecular communications and the Internet of (Bio) Nano Things. The citations to this work is at 2289, according to Google Scholar, with an h-index of 22.

    Dr. Balasubramaniam co-founded a new workshop series called Institute of Electrical and Electronic Engineering (IEEE) Molecular and Nano Communication (MoNaCom), which ran from 2011 – 2013, and most recently he co-founded the ACM International Conference on Nanoscale Computing and Communication (ACM NanoCom). In 2014, he was the Technical Program Committee co-chair, and in 2015 he was the General Chair of ACM NanoCom. He serves as an Associate Editor for IEEE Internet of Things journal, Editor of Elsevier Nano Communication Networks, and Editor of Digital Communication Networks. He also serves as a technical program committee member for a number of conferences (e.g., IEEE INFOCOM, IEEE MASS, IEEE LCN). Dr. Balasubramaniam is also a grant reviewer for National Science Foundation, Academy of Finland, as well as the Agence Nationale De La Recherche.

    Michael BarrosDr. Michael Taynnan Barros (male), First Time FET Participant, is currently an Irish Research Council Government of Ireland Postdoctoral research fellow associated with the TSSG, WIT. Michael received his Ph.D. in Telecommunication Software at the Waterford Institute of Technology in 2016, M.Sc. degree in Computer Science at the Federal University of Campina Grande in 2012 and B.Tech. degree in Telematics at the Federal Institute of Education, Science and Technology of Paraiba in 2011. He has published over 40 research papers in diverse journals such as IEEE Transactions on Communications, IEEE Transactions on Nanotechnology, and conferences in the area of wireless communications, optical communications, ad-hoc networks, as well as molecular and nano scale communications. He is also a reviewer for many journals and participated as technical program committee and reviewer for various international conferences. In 2017, he was the Technical Program Co-chair for the 3rd International Workshop on Nanoscale Computing and Communications (NsCC), held in conjunction with the NEW2AN conference, the chair of the 5GPPP Network Management, QoS and Security Working Group and the Chair of the 2nd Network Management, QoS and Security for 5G Networks held in conjunction with the EuCNC. His research interests include Internet-of-things, Terahertz communications, Nano networks and Molecular Communications. 

    Daniel MartinsDaniel Perez Martins (male), First Time FET Participant, was born in Salvador-BA, Brazil, 1985. Currently, he is a researcher associated with the Telecommunications Software and Systems Group, Waterford Institute of Technology. Daniel received his M.Sc. degree in Electrical Engineering at the Federal University of Campina Grande (UFCG-Brazil-2013) and B.Sc. degree in Telecommunications Engineering at the University Center Jorge Amado (Unijorge-Brazil-2009). During his Master, he was associated with Institute for Advanced Studies in Communications (Iecom) where worked on a R&D project to identify the acoustical noise's source at an industrial environment using Sound Signal Processing and Stochastic Processes techniques. His experiences concentrates on Mathematical Modeling of Telecommunications Systems, Signal Processing and Analysis, Computer Networks and Molecular Communications. He is also a reviewer for the Nano Communications Networks and for the IEEE Internet of Things journals. His research interests include Bacteria-Based Nanosystems, Synthetic Biology and Molecular Communications.

    Frances ClearyFrances Cleary (Female) First Time FET Participant, is currently Research Unit Manager for the Mobile Ecosystem and Pervasive Sensing (MEPS) Research Unit in TSSG, Waterford Institute OF Technology. Since joining WIT/TSSG Frances has worked in the following main thematic research areas (as task leader, work package leader and project manager/coordinator): Pervasiveness in converged telecommunications, user-centric paradigm for seamless mobility in Future internet, federated testbed management and Embedded software quality assurance and testing. Frances has multiple years of experience as a EU Project coordinator of SecCord and Effectsplus EU FP7 CSA funded research projects that relates to trust and security (responsible for security research project clustering, leading to increased collaboration, dissemination, networking strategic research agenda’s, roadmapping and research to industry translation. Frances has also successfully Project coordinated and actively lead the Cybersecurity & Privacy (CSP) Forum initiative www.cspforum.eu  funded via the EU FP7 SecCord project, this project focused on EU research collaboration, networking  and clustering activities of funded EU trust and security research projects. With 12 years’ experience of working in EU funded research projects, Frances also over the past 2 years has specifically been focusing on smart and connected mobility research topics and has a direct interest in urban mobility, transport and automotive related research thematic areas (e.g. ADAS, MaaS, intelligent/Smart transport and mobility and the adoption and use of ICT technologies to intelligent transport systems, physical Internet). Frances recently actively worked on the EU H2020 funded project called DISCOVERY http://discoveryproject.eu/ , that specifically focused on international cooperation supporting dialogues between Europe and North America (US and Canada). Here she actively contributed to working group activities relating to funding mechanisms and Cybersecurity, fostering cooperation in collaborative ICT Research & Innovation, and she contributed to the annual Transatlantic ICT Forum. Currently France’s unit has expertise relating to Pervasive sensing, Embedded Systems Communications and Bio-Nano Communications. The Unit specifically focuses on new innovations and application of new emerging technologies in the health vertical.


    Ilangko BalasinghamProf. Ilangko Balasingham (male) First Time FET Participant, received the M.Sc. and Ph.D. degrees from the Department of Electronic Systems, NTNU in 1993 and 1998, respectively, both in signal processing and wireless communications. He performed his Master’s degree thesis at the Department of Electrical and Computer Engineering, University of California Santa Barbara, USA. He co-founded Fast Search & Transfer ASA in Oslo in 1998 and worked there as a R&D Engineer developing image and video streaming solutions for mobile handheld devices until 2002. The company was later acquired by Microsoft Inc. for 1 billion US$ and was named as Microsoft Development Center Norway. Since 2002 he has been with the Intervention Center, Oslo University Hospital, where he heads the Wireless Biomedical Sensor Network Research Group. He was appointed Full Professor of Medical Signal Processing and Communications at NTNU in 2006. For the academic year 2016/2017 he was Professor by courtesy at the Frontier Institute, Nagoya Institute of Technology in Japan.

    Ilangko’s lab has expertise in nanoscale communication technologies, wireless communication system, antenna design, statistical signal processing and machine learning, and clinical medicine.  His research interests include super robust short range communications for both in-body and on-body sensors, body area sensor network, microwave short range sensing of vital signs, short range localization and tracking mobile sensors, and nanoscale communication networks.

    Ilangko has supervised 16 Postdocs, 10 PhDs and 25 Master students and has a group of 4 Postdocs and 7 PhD students.  He has authored or co-authored over 220 journal and full conference papers, 7 book chapters, 42 abstracts, 5 patents, and 16 articles in popular press, and has given 16 keynotes at the international conferences. According to Google scholar he has 2200 citations and H-index of 25. He also is active in organizing conferences (Steering Committee Member of ACM NANOCOM 2018-2021; General Chair: the 2019 IEEE Int. Symposium of Medical ICT, the 2012 Body Area Networks (BODYNETS) conference; TPC Chair of the 2015 ACM NANOCOM) and serving in the editorial boards (Area Editor of Elsevier Nano Communication Networks and Guest Editor of IEEE  J. of Biomedical and Health Informatics).

    Christopher ContagDr. Christopher Contag (male) First Time FET Participant is an Adjunct Professor of Biomedical Engineering at NTNU. He joined Michigan State University in 2017 as the founding director of the Institute for Quantitative Health Science and Engineering (IQ) and the inaugural chair of the new Department of Biomedical Engineering in the College of Engineering. He is also a professor in the Department of Microbiology and Molecular Genetics. As professor emeritus in the department of pediatrics at Stanford University he maintains connections to various programs and departments at Stanford. Dr. Contag received his B.S. in Biology from the University of Minnesota, St. Paul in 1982. He received his Ph.D. in Microbiology from the University of Minnesota, Minneapolis in 1988, where he did his dissertation research on the topic of viral infections of the central nervous system. He was a postdoctoral fellow at Stanford University from 1990-1994 in the Department of Microbiology where he studied mother-to-infant transmission of HIV, and then joined the faculty in Pediatrics at Stanford in 1995 with a joint appointment in Microbiology and Immunology and courtesy appointments in Bioengineering and Radiology. Dr. Contag served as the Associate Chief of the Division of Neonatal and Developmental Medicine, the director of Stanford’sCenter for Innovation in In Vivo Imaging (SCI3) and co-director of both the Molecular Imaging Program at Stanford (MIPS) and Child Health Research Institute (CHRI) at Stanford University. Dr. Contag has developed and used noninvasive imaging approaches to reveal molecular processes in living subjects, to understand host pathogen interactions, to advance diagnostic and therapeutic strategies for cancer, and to reveal the nuances of stem cell engraftment and expansion. The initial imaging tools imaged biological functions at the macroscopic scale and this has led to a need to develop tools for imaging at the microscopic scale—these include miniature confocal microscopes that reach into the body for early diagnosis, and Raman-based endoscopes. Dr. Contag’s work with extracellular vesicles (EVs), exosomes and micro-vesicles, has focused on their biological and diagnostic relevance as well as engineering EVs as drug delivery systems. Dr. Contag is a founding member, and past president of the Society for Molecular Imaging (now part of WMIS) and recent past president and a Fellow of WMIS. For his fundamental contributions in the field of molecular imaging, he was awarded the Achievement Award from the Society for the Molecular Imaging. For his fundamental contributions to the field of optics he was awarded the Britton Chance Award from the International Society for Optics and Photonics (SPIE). Dr. Contag was a founder of Xenogen Corp., now part of PerkinElmer, a company with the mission of commercializing in vivo bioluminescence and fluorescence imaging, and is a founder of BioEclipse Inc., a company aimed at improving cancer immunotherapy, and a founder of PixelGear, a point-of-care pathology company.

    Masamitsu KanadaProf. Masamitsu Kanada (male), First Time FET Participant, is an assistant professor at Michigan State University and visiting professor at NTNU. In graduate school, Dr. Kanada studied cell biology and fluorescence live cell imaging in the laboratory of Dr. Taro Q.P. Uyeda at Tsukuba University in Japan. After completing PhD study, He started working in a pharmaceutical company, Oncotherapy Science Inc., developing cancer therapies. As his postdoc training, he learned intravital microscopy and whole body preclinical imaging in the laboratory of Dr. Susumu Terakawa at Hamamatsu University School of Medicine and Dr. Christopher H. Contag at Stanford University. His research focus is to address questions in cancer biology using multidisciplinary approaches. He is currently advancing the understanding of extracellular vesicle (EV)-mediated cell-to-cell communication, and engineering EVs to create a novel gene delivery system.

    Ali KhaleghiProf. Ali Khaleghi (male), First Time FET Participant received B.Sc. and M.Sc. degrees from AmirKabir University of Technology (AUT) and Iran University of Science and Technology (IUST) in Electrical and Telecommunication engineering in 1997 and 1999, respectively. He worked for two years with Iran Electronic Industries as satellite system designer.  He received Ph.D. in Physics from the University of Paris South (Paris XII) at the École Supérieure d'électricité (SUPELEC), Paris, France in 2006. He was a postdoctoral researcher at the Institut d' Eectronique et de Télécommunications de Renne (IETR) and was postdoctoral at the IVS- Oslo University Hospital for four years. He was visiting researcher at the biomedical department of the Chalmers University of Technology, Gothenburg, Sweden. He was appointed as Associate Professor of Telecommunication Engineering Department at K.N.Toosi University of Technology (KNTU), Tehran, Iran in 2010. He taught four different courses for graduate and undergraduate students. He has supervised 22 Master thesis, and 21 bachelor projects also is supervisor for two PhD students. He has granted more than ten R&D projects during his career at KNTU with a total value of 1.5 M€. He has established Wireless Terminal Test Lab (WTT) at KNTU where he is the head of the Lab. He distinguished as the best researcher of KNTU in 2013 and 2014. He was the head of the telecommunication group in 2012-2013. From, 2014, he is an adjunct professor at KNTU and researcher at Norwegian University of Technology and Oslo University Hospital. He is expertise in electromagnetic and waves propagation, antenna design, electromagnetic compatibility (EMC), signal processing, measurement techniques and bio-electromagnetics. He has authored over 85 journal and full conference papers, 2 book chapters, 3 patents. He was a member of organiser committee for BODYNETS in 2012. According to Google Scholar, he has 893 citations and H-index of 17.


    Hagen BriesenProfessor Dr. Hagen v. Briesen (male), First Time FET Participant, is Director of Division “Medical Biotechnology” at the Fraunhofer Institute for Biomedical Engineering (IBMT in Sulzbach/Saar, Germany) and Professor for Experimental Hematology at the University of Saarland. He studied biochemistry at the University of Frankfurt/Main (PhD in 1990). Since 2001 he had been assistant professor for Experimental Hematology at the University of Regensburg. He is Principle Investigator of the Global HIV Vaccine Research Cryorepository (GHRC, Collaboration for AIDS Vaccine Discovery (CAVD)) (Bill & Melinda Gates Foundation), and is involved in joint research projects in cell programming by nanoscaled devices and nanoparticulate drug delivery systems to overcome biological barriers such as the blood-brain barrier (EU, BMBF and Federal Armed Forces). He is external expert in an interdisciplinary EU-funded support action on HIV-MTB co-infection “EUCO-Net”. He is co-founder of a start-up company (Analysis GmbH) for virus validation and safety studies where he introduced Good Laboratory Practice (GLP) as test facility manager. Hagen von Briesen was Principal Investigator of the Centralized Facility for the Isolation and Characterization of HIV within the WHO-Network, Global Program on AIDS, organized by the Joint United Nations Program on HIV/AIDS (UNAIDS). HIV-1 strains from different parts of the world were systematically isolated in his laboratory and characterized by the WHO Network. Concurrently, he was member of the trial management committee of the Mother-to-Child HIV-1 Transmission Study (UNAIDS-sponsored PETRA study) functioning as Head of Centralized Repository Centre and test laboratory. As of late, he is director of the Environmental Specimen Bank (UPB-human) of the Federal German Government.

    Sylvia WagnerDr. Sylvia Wagner (female), First Time FET Participant, is Head of the Department “Bioprocessing & Bioanalytics” at Fraunhofer IBMT. She studied chemistry at the University Karlsruhe. She gained her PhD thesis in the group of Prof. Dr. H. v. Briesen at IBMT. From 2008-2016 she was group manager at IBMT and became head of department in 2015. Her main research topics are focused on nanobiotechnology and development of preclinical in vitro/ex vivo models in the field of nanotoxicology as well as nanomedicine. Nanoparticulate formulations for the specific drug targeting as well as for crossing of biological barriers were preclinically tested in different in vitro and ex vivo cell culture models. Her department has established e.g., several blood-brain barrier cell culture models, a gastrointestinal barrier model, a lung model and a dermal barrier model for permeation studies. Her department was and still is involved in several joint research projects in the field of drug delivery systems based on nanotechnologies which were and are funded by EU and BMBF (“NanoDrug”; “NanoCancer”; “NanoBrain”; “BioTrap for CCC”) as well as projects supported by the German Federal Armed Forces and the private industry. One of her actual projects called “GITCare” is focused on the oral delivery of nanoparticulate packaged drugs for tumour therapy. Furthermore, several projects based on nanoparticle risk assessment are coming more and more into focus, e.g., the BMBF funded projects “MINAC” and “NanoUmwelt” and the EU funded project “HISENTS”.

    Julia NeubauerDr. Julia Neubauer (female), First Time FET Participant, is Head of the Department “Cryo & Stem Cell Technology” at Fraunhofer IBMT. She studied Biology at the Julius-Maximilians-University of Würzburg and received her PhD in 2012 after joining Fraunhofer IBMT as project manager five years before. During these years she spent also some time abroad, visiting the University of Vienna/Austria and the University of Coquimbo/Chile for research stays and the evaluation of process techniques. Since 2012 she was leading the work group “Cell Culture Automatization” at Fraunhofer IBMT in St. Ingbert. Since 2015 Julia Neubauer was appointed Head of Department. Her main research topics are focused on establishing new automation procedures for the optimization of stem cell workflows using suspension bioreactors and robotic/microfluidic platforms. For this, cell culture protocols are adapted and improved, for example by using biopolymers as microcarrier system. Besides, innovative cryopreservation procedures are developed for the efficient storage of high-quality cell material.

    Marc FournelleDr. Marc Fournelle (male), First Time FET Participant, is Head of Business Area “Biomedical Ultrasound“ at Fraunhofer IBMT. He studied Physics at the University of Saarland and Barcelona and received his PhD in 2009 after joining the Ultrasound Department of Fraunhofer IBMT in 2005. Since 2011 he was head of the work group “Biomedical Ultrasound Research”, became Head of Department “Medical Ultrasound” in 2015 and is now Head of Business Area “Biomedical Ultrasound” since 2016. His main areas of research are ultrasound and optoacoutic imaging, signal processing and reconstruction algorithms, as well as therapeutic ultrasound.

     Ina MeiserDr. Ina Meiser (female), First Time FET Participant leads the work group “Cryobiotechnology” that focusses in lab automation, especially regarding hiPSCs research and novel cryopreservation approaches.


    © 2019 Gladiator Project. All Rights Reserved.